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Abstract
Borrelia burgdorferi, the bacterial pathogen of Lyme borreliosis, differentially expresses select genes in vivo, likely
contributing to microbial persistence and disease. Expression analysis of spirochete genes encoding potential membrane
proteins showed that surface-located membrane protein 1 (lmp1) transcripts were expressed at high levels in the infected
murine heart, especially during early stages of infection. Mice and humans with diagnosed Lyme borreliosis also developed
antibodies against Lmp1. Deletion of lmp1 severely impaired the pathogen’s ability to persist in diverse murine tissues
including the heart, and to induce disease, which was restored upon chromosomal complementation of the mutant with
the lmp1 gene. Lmp1 performs an immune-related rather than a metabolic function, as its deletion did not affect microbial
persistence in immunodeficient mice, but significantly decreased spirochete resistance to the borreliacidal effects of anti-B.
burgdorferi sera in a complement-independent manner. These data demonstrate the existence of a virulence factor that
helps the pathogen evade host-acquired immune defense and establish persistent infection in mammals.
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Introduction
Lyme borreliosis, caused by Borrelia burgdorferi sensu lato, is the
most prevalent tick-borne human disease in the United States,
Europe and many parts of Asia [1]. Once the pathogen is
deposited in the mammalian dermis by feeding Ixodes ticks, it
establishes a localized infection at the bite site, then disseminates to
distant cutaneous sites and various internal organs, including the
spleen, bladder, joints, heart and central nervous system [1–3].
While B. burgdorferi persists in several tissue locations in mammals,
only a limited set of organs, most frequently the joints and the
heart, experience robust host-inflammatory responses resulting in
clinical complications, such as Lyme arthritis and carditis.
Antibiotic treatment is usually, but not always, successful, and
some patients develop a form of antibiotic-resistant arthritis that is
thought to be unrelated to persistent infection [4].
The B. burgdorferi transcriptome undergoes dynamic changes
during the complex enzootic cycle of the spirochetes [5–8]. B.
burgdorferi grown in laboratory medium or within host-implanted
dialysis membrane chambers readily responds to altered environ-
ments, adapting to changes in temperature, pH, nutrients, and
host immune responses [6,9–15]. A significant fraction of the B.
burgdorferi genome (8.6%), or 150 genes, could be differentially
expressed in vitro in response to physiochemical alterations in
growth conditions, and a major proportion of these genes (46%)
encode proteins with predicted export signals [13]. However,
while all B. burgdorferi lipoproteins have outer membrane export
signals, some are retained in the periplasm by sequence-specific
signals [16]. Studies have identified a few B. burgdorferi genes which
are preferentially expressed in specific mammalian and arthropod
environments and gene deletion studies [17] have confirmed that
some of those differentially-expressed gene products support
spirochete infectivity. For example, the B. burgdorferi genes bbk32,
dbpA/B and bmpA/B are selectively expressed in mammals and
facilitate B. burgdorferi infection of the murine host [8,18,19]. In
contrast, ospA/B, bb0365 and bb0690 are highly expressed during
specific stages of B. burgdorferi persistence in ticks and support the
spirochete life cycle in the arthropod [7,20,21]. Other genes, such
as ospD is dispensable for infectivity [22,23], regardless of tightly
regulated expression in vivo [22]. As gene duplication is a crucial
mechanism of evolutionary innovation and the B. burgdorferi
genome harbors significant clusters of paralogous genes in addition
to large numbers of unique genes with unknown functional
annotations [24,25], many spirochete proteins may have func-
tional redundancy. Thus, despite selective expression and
beneficial contribution to the spirochete life cycle, antigens could
be functionally redundant and non-essential for infectivity.
Therefore, further identification of virulence genes that have
significant impact on B. burgdorferi survival in vivo and pathogenesis
is important for the development of preventative strategies.
The clinical complications of Lyme borreliosis are primarily
triggered by B. burgdorferi-induced host inflammatory responses
[26–28]. Although spirochetes colonize a wide variety of host
tissues, the inflammatory response that results in pathology is
observed in a limited set of host organs, most commonly in one or
both mouse ankles or human knees and the heart. The diversity of
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microbial antigens that are expressed at higher levels in a time- or
tissue-specific manner may assist in B. burgdorferi persistence in local
environments, antigens, especially those exposed on the microbial
surface, could directly participate in host–pathogen interactions
contributing to the genesis of organ-specific pathogenesis.
Therefore, we assessed the expression levels of a selected set of
B. burgdorferi genes in diverse murine tissues because of their
putative membrane localization. We sought to determine if B.
burgdorferi gene products that are preferentially expressed at high
levels in clinically-relevant host microenvironments directly
contribute to microbial virulence. The characterization of
microbial ligands that are differentially expressed during the
pathogen’s life cycle is important for the identification of novel
vaccine targets and the prevention of the multi-system disorders
caused by B. burgdorferi.
Results
Identification of B. burgdorferi genes that are expressed
in higher levels in infected murine tissues
B. burgdorferi persists in diverse tissue environments of the
mammalian host. To identify B. burgdorferi genes that are expressed
at high levels in vivo, particularly in a tissue-specific manner, we
employed a sensitive quantitative RT-PCR (qRT-PCR) approach
to compare spirochete transcriptomes in multiple murine tissues
and in vitro. A total of 91 spirochete genes were selected for
expression analysis, based on their putative association with the
spirochete membrane as determined by the database annotation
and in silico analysis for extracellular exposure (Table S1). Groups
of C3H/HeN mice (5 animals/group) were challenged with B.
burgdorferi (10
5 cells/mouse) and skin, joints, heart and bladder
tissue were collected following 1, 2, 3 and 4 weeks of infection.
Total RNA was isolated, and corresponding tissues from the
indicated time points were combined into four separate pools of
skin, joint, heart and bladder samples. qRT-PCR analysis was
performed using gene-specific primers as detailed in the Materials
and Methods section. Analysis of qRT-PCR data revealed that 44
B. burgdorferi genes (out of 91 assessed) were not transcribed at
detectable levels in vivo. The remaining 47 genes displayed variable
expression across different tissues, which is presented as fold
increase in transcript levels relative to flaB, together with
corresponding in vitro expression levels (Figure S1). B. burgdorferi
bb0210, annotated as surface-located membrane protein 1 (lmp1),
which encodes an exported protein with type I signal peptide with
unknown function [25], displayed the most dramatic differential
expression in murine tissues, with the highest level of expression
found in the heart (Figure S1).
lmp1 is dramatically expressed in the murine heart
during early B. burgdorferi infection
We used the initial qRT-PCR screen as a guide to focus on
genes of potential importance, and performed more detailed
temporal and spatial expression analyses of lmp1 throughout the B.
burgdorferi infection in mice. A similar qRT-PCR experiment
(Figure S1), using separate RNA samples collected at weekly
intervals, showed that lmp1 was expressed at high levels between
weeks 1 and 2, but produced at low levels between weeks 3 and 4
(data not shown). Therefore, a detailed expression analysis of lmp1
focused on the early phases of B. burgdorferi infection in the murine
host. To accomplish this, groups of C3H/HeN mice (5 animals/
group) were infected with B. burgdorferi, and tissues were isolated at
7, 10, 15, and 20 days. Isolated total RNA was converted to cDNA
and subjected to qRT-PCR to measure copies of lmp1 transcripts,
relative to flaB expression. The expression of lmp1 was selectively
upregulated in the heart at 7 and 10 days post-infection, compared
to that in the skin, joints, bladder and infected ticks (Figure 1).
Similar to syringe-based infection, the expression of lmp1 was also
significantly higher in infected hearts compared to other tissues,
when mice were infected via natural tick-borne B. burgdorferi
infection. The expression of lmp1 in the murine heart, analyzed at
day 7 following B. burgdorferi–infected tick challenge, was
significantly higher than corresponding lmp1 expression levels in
the infected skin, bladder and joints (Figure S2). Consistent with
Author Summary
The pathogen of Lyme borreliosis, Borrelia burgdorferi,
causes disease in many parts of the world, resulting in
multi-system complications in infected humans and
animals. The microbe produces certain antigens in
response to host environments that potentially allow it
to persist and cause disease. Here, we analyzed the
expression of B. burgdorferi genes encoding potential
membrane proteins in infected hosts and show that one of
them, termed Lmp1, is dramatically expressed in infected
mice, most prominently in cardiac tissue during early
infection. Mice and humans diagnosed with Lyme
borreliosis also develop antibodies against Lmp1. Deletion
of lmp1 in an infectious isolate of B. burgdorferi impairs the
pathogen’s ability to persist in murine tissues, especially
the heart, and to induce disease, which was reversed when
the gene was inserted back into the chromosome of the
mutant. Lmp1 performs an immune-related, rather than
a metabolic, function as its deletion does not affect
microbial persistence in immunodeficient mice, but
decreases the spirochete’s ability to resist the borreliacidal
effects of anti-B. burgdorferi sera. These data identify the
existence of a surface-located antigen of B. burgdorferi that
helps the pathogen evade host-acquired immune defense
and establish persistent infection and disease in mammals.
Figure 1. B. burgdorferi lmp1 is dramatically upregulated during
early phases of spirochete infection of the murine heart. Total
RNA was isolated from murine heart, skin, bladder, and joints of B.
burgdorferi–infected mice (5 mice/group) at days 7, 10, 15, and 20,
following spirochete challenge, as well as from engorged nymphs that
fed on 2-week–infected mice, which were then converted to cDNA for
measuring lmp1 transcripts using quantitative PCR. The relative
expression levels of lmp1 are presented as copies of lmp1 transcript
per 1,000 copies of flaB transcripts. Bars represent the mean6SEM from
quantitative PCR analyses of three independent infection experiments.
The transcript levels of lmp1 in the heart on days 7 and 10 were
significantly higher than all time points for the skin, joint, bladder, and
tick (*P,0.01–0.001).
doi:10.1371/journal.ppat.1000326.g001
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patients with diagnosed Lyme disease also developed detectable
antibody responses to Lmp1 (Figure S3). These results suggest that
lmp1 encodes an immunogenic antigen that is expressed in vivo,
with dramatic expression in the murine heart in both syringe and
tick-transmitted B. burgdorferi infection. Therefore, we further
examined the role of Lmp1 in B. burgdorferi virulence in mice.
lmp1 deletion interferes with the ability of the mutant B.
burgdorferi to persist in murine tissues and to induce
disease
Although the function of B. burgdorferi Lmp1 is unknown, the
protein displays putative conserved domains including unique
repeat modules housed in the central portion of the protein
(Figure 2A). Polyclonal antibodies that specifically recognized
native B. burgdorferi Lmp1 were generated (Figure S4) and used in a
proteinase K accessibility assay, which indicated that Lmp1 is
exposed on the microbial surface (Figure 2B). To further study the
role of the Lmp1 in B. burgdorferi infectivity, we created lmp1-
deficient B. burgdorferi. An isogenic mutant of lmp1 was created by
replacing part of the lmp1 open reading frame with a kanamycin
resistance cassette via homologous recombination (Figure 2C). A
DNA construct was generated for the intended recombination,
sequenced to confirm identity and transformed into B. burgdorferi as
detailed in the Materials and Methods section. Transformants
were further screened using PCR analysis to ensure that the
antibiotic cassette was inserted into the intended chromosomal
locus (Figure 2D), and that the plasmid profiles of the wild type
and mutant spirochetes were identical (data not shown). RT-PCR
analysis showed that while lmp1 mRNA was undetectable in the
lmp1 mutant, similar to the parental isolate, the mutant was able to
transcribe the surrounding genes, bb0209 and bb0211 (Figure 2E).
qRT-PCR analysis further confirmed that the transcript levels of
bb0209 and bb0211 in the lmp1 mutant were 95(69%) and 85
(68%) of the respective wild type levels (data not shown). The lmp1
mutant spirochetes contained a similar protein profile to that of
the wild type (Figure 2F, left panel) and, as expected, the lmp1
mutant did not produce Lmp1 protein (Figure 2F, right panel). We
next compared the murine infectivity of lmp1 mutant B. burgdorferi
with that of the parental isolates. Groups of 10 C3H/HeN mice
were inoculated intradermally with equal numbers of wild type or
lmp1 mutant B. burgdorferi (10
5 spirochetes/mouse). qRT-PCR
analysis (Figure 2G) and culture (data not shown) of murine skin
biopsy and blood samples collected following one week of infection
indicated that both lmp1 mutants and wild type spirochetes were
readily detectable in skin and blood. When Ixodes ticks were
allowed to feed on mice inoculated with lmp1-deficient B. burgdorferi
after two-weeks of infection, the mutants were able to migrate into
feeding ticks (data not shown).
Although these observations indicated that lmp1 mutant B.
burgdorferi was infectious in the murine host, the mutant was unable
to establish persistent infection in mice and failed to induce
disease, as assessed by the development of arthritis and carditis. To
rule out the possibility that the observed phenotypic defects of the
lmp1 mutant B. burgdorferi to infect the murine host were the result
of anomalous effects of genetic manipulation, we sought to
complement the lmp1 mutant spirochetes with a wild type copy of
the lmp1 gene in cis, and use this isolate in murine infection studies.
As lmp1 lacks an obvious upstream promoter, we first fused the
open reading frame of lmp1 with the B. burgdorferi flaB promoter.
The flaB-lmp1 fusion, along with the streptomycin resistance
cassette, aadA [29] was then inserted into pXLF14301 [20] for
integration into the B. burgdorferi chromosome (Figure 3A). lmp1
mutants were transformed and selected using antibiotics. PCR
analysis confirmed that one of the lmp1-complemented spirochete
isolates retained all of the B. burgdorferi plasmids present in the
parental isolate (data not shown). RT-PCR and immunoblotting
showed that the lmp1-complemented isolate produced both lmp1
mRNA (Figure 3B) and Lmp1 protein (Figure 3C). Lmp1 mRNA
and protein production in the complemented and wild type
isolates was further assessed by qRT-PCR and densitometric
analysis of the immunoblot (Figure 3C), respectively, and
normalized against FlaB production, which indicated that both
isolates produced comparable levels of Lmp1 (data not shown).
We then compared the ability of the wild type, lmp1 mutant and
complemented spirochetes to establish infection and induce
disease in the murine host. Groups of 10 C3H/HeN mice were
separately inoculated intradermally with wild type, lmp1 mutant
and lmp1-complemented B. burgdorferi (10
5 cells/mouse). The
spirochete burdens in heart, skin, bladder and joints were
evaluated at day 7, 10, 15, 21 and 28 following B. burgdorferi
infection. The results showed that, except for the initial time point
(day 7), lmp1 mutants were severely impaired in their ability to
colonize all murine tissues and were undetectable in the heart after
10 days of infection (Figure 3D). Similarly, culture analysis of
murine heart isolated after 15 days of B. burgdorferi infection
showed that the lmp1 mutant spirochetes could not be recovered
(data not shown). In contrast, both wild type and lmp1-
complemented B. burgdorferi readily persisted in all tested murine
tissues throughout infection, with significantly higher burdens than
lmp1-deficient spirochetes–heart (P,0.001), skin (P,0.006), blad-
der (P,0.004) and joints (P,0.002). Both wild type and lmp1-
complemented B. burgdorferi caused severe inflammation, but lmp1
mutants induced less severe disease, as reflected by the
histopathological signs of carditis (Figure 4A and 4B), development
of swelling in the tibiotarsal joints (Figure 4C), and histopatholog-
ical signs of arthritis (Figure 4D). In most cases, the tissue burdens
of lmp1-complemented isolates (Figure 3D) and their ability to
induce inflammation (Figure 4B and 4C) were comparable, yet
significantly lower (P,0.05), than those of the wild type isolates,
possibly due to the constitutive expression of lmp1 from the
heterologous flaB promoter which might be detrimental to
spirochetes.
lmp1 contributes to B. burgdorferi survival against host-
acquired immune defenses
The analysis of spirochete growth in the culture media indicated
that the wild type, lmp1 mutants and lmp1-complemented isolates
follow a similar growth pattern without significant variation in
motility or obvious morphological defects (data not shown).
However, lmp1 mutants were impaired to persist in the
immunocompetent murine hosts following the first week of
infection. We next assessed whether Lmp1 function in vivo is
related to the metabolic or immune environment of the host. To
accomplish this, we compared the infectivity of wild type and lmp1
mutant B. burgdorferi in the established immunodeficient murine
model of Lyme borreliosis using severe combined immunodefi-
cient (SCID) mice [30]. Groups of SCID mice (3 animals/group)
were inoculated intradermally with 10
5 wild type, lmp1 mutant, or
lmp1-complemented B. burgdorferi. The spirochete burdens in the
heart, skin, bladder, and joints were evaluated at day 7, 14 and 21
following B. burgdorferi infection using quantitative PCR. In
parallel, the viability of the spirochete was determined by culture
of murine blood and spleen isolated at day 7, 14 and 21. The
results showed that the wild type, lmp1 mutant and lmp1-
complemented B. burgdorferi could be cultured from murine tissues
at all time points (data not shown) and that there was no significant
difference in B. burgdorferi burdens in all tested murine tissues
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PLoS Pathogens | www.plospathogens.org 3 March 2009 | Volume 5 | Issue 3 | e1000326Figure 2. Construction and analysis of lmp1 mutant B. burgdorferi. (A) Schematic diagram representing putative domain features of the Lmp1
protein. Amino acid positions at the beginning of the putative domains are indicated on the top. The leader peptide cleavage site predicted by
SignalP 3.0 [58] is located after the 25
th amino acid position. The central region of the protein harbors seven unique repeat domains of 54 amino acids
(indicated in gray letters), previously identified to house a potential B. burgdorferi adhesin motif [34]. The carboxyl terminal region contains putative
conserved domains similar to tetratricopeptide repeat (TPR) or a pilus assembly protein, as identified by NCBI BLASTP conserved domains search
program. Lmp1 sequence can be accessed via JCVI B. burgdorferi genome page with the locus tag BB_0210 or via GenBank accession number
AAC66595.1 (B) Lmp1 is sensitive to proteinase K–mediated degradation of B. burgdorferi surface proteins. Viable spirochetes were incubated with (+)
or without (2) proteinase K for the removal of protease-sensitive surface proteins and processed for immunoblot analysis using Lmp1 antibodies. (B)
burgdorferi OspA and FlaB antibodies were utilized as controls for surface-exposed and sub-surface proteins, respectively. (C) Schematic drawings of
the wild type isolate (WT) and the lmp1 mutant B. burgdorferi (lmp1
2) at the bb0210 (lmp1) locus (gray box arrow). Genes bb0208, bb0209, and bb0211
(white box-arrows) and the kanamycin-resistance cassette driven by the B. burgdorferi flaB promoter (flaB-Kan, black box-arrow) are indicated.
Nucleotide positions of primers P1–P4 in the B. burgdorferi genomic database (www.tigr.org) are indicated. Seven nucleotides’ overlap between the
end of bb0209 and the start of bb0210 was not deleted in the allelic exchange by extending the primer P2 until the end of bb0209. The 59 and the 39
arms for homologous recombination flanking upstream and downstream of the lmp1 locus were amplified using primers P1–P2 and P3–P4 (black
arrowheads), and ligated to the flaB-Kan cassette as detailed in Materials and Methods. (D) Integration of the mutagenic construct, flaB-Kan, in the
intended genomic locus. Primers 5–9 (gray arrowheads, positions indicated in Figure 2C) were used for PCR analysis with isolated DNA from wild type
or lmp1 mutant B. burgdorferi as templates. (E) RT-PCR analysis of wild type or lmp1 mutant B. burgdorferi. Total RNA was isolated from cultured
spirochete, and transcript levels of lmp1, flaB, bb0209, and bb0211 were detected by RT-PCR analysis. (F) The lysates of wild type and lmp1 mutant B.
burgdorferi were separated on a SDS-PAGE gel and either stained with Coomassie blue (left) or transferred onto a nitrocellulose membrane and
probed with the antiserum against Lmp1 or FlaB (right). Migration of protein standards is shown to the left in kDa. (G) The lmp1 mutant B. burgdorferi
were capable of dissemination from the dermis of infected mice. Skin and blood samples were collected from mice seven days after challenge, and
the B. burgdorferi load was analyzed by quantitative PCR measurement of flaB copies and presented as flaB/murine b-actin.
doi:10.1371/journal.ppat.1000326.g002
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PLoS Pathogens | www.plospathogens.org 4 March 2009 | Volume 5 | Issue 3 | e1000326Figure 3. Complementation of lmp1 mutant B. burgdorferi with lmp1 gene restores the ability of spirochetes to persist in mice. (A)
Construction of DNA construct (pXLF14301-Lmp1) for chromosomal integration of the lmp1 gene. The open reading frame of lmp1 gene was fused
with B. burgdorferi flaB promoter and cloned into the shuttle vector pKFSS1 that houses the streptomycin resistance gene (aadA) under B. burgdorferi
flgB promoter. A DNA fragment encompassing the lmp1 gene with the flaB promoter and aadA cassette was finally excised from pKFSS1 and cloned
into BamHI and SmaI sites of pXLF14301, which contains two fragments from B. burgdorferi chromosomal locus (bb0444 and bb0446) that act as the 59
and 39 arms needed for homologous recombination and integration of the complemented gene in B. burgdorferi chromosome. (B) RT-PCR analysis of
the lmp1 transcripts. Total RNA was isolated from either the wild type (WT), lmp1 mutant (lmp1
2), or lmp1-complemented B. burgdorferi (lmp1 Com),
converted to cDNA, then subjected to PCR analysis with flaB and lmp1 primers, and analyzed on a 2% agarose gel. (C) Production of the Lmp1 protein
by the complemented B. burgdorferi. Lysates of B. burgdorferi were separated on a SDS-PAGE gel, which was either stained with Coomassie blue (left)
or transferred to nitrocellulose membrane, and blotted with antiserum against Lmp1 or FlaB (right). (D) The B. burgdorferi burden in mice. Mice were
Borrelia Antigen Essential for Host Virulence
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burdens of wild type and genetically-manipulated pathogens in
SCID mice, one of the innate immune mechanisms, the ability of
macrophages to phagocytose invading pathogens, which is
important in controlling B. burgdorferi infection, did not differ
between wild type and lmp1 mutants (Figure 5B). As neutralizing
infected with wild type (white bar), lmp1 mutant (gray bar), and lmp1 mutant complemented with lmp1 (black bar) B. burgdorferi, and the spirochete
burden was analyzed at days 7, 10, 15, 21, and 28 by measuring copies of the B. burgdorferi flaB gene, which was then normalized to mouse b-actin in
each sample. Bars represent the mean6SEM of relative tissue levels of B. burgdorferi from three independent animal infection experiments. With the
exception of the day 7 time point, levels of lmp1-complemented isolates were significantly higher than those of lmp1 mutants in all timepoints and
murine tissues (* heart, P,0.001; skin, P,0.006; bladder P,0.004, joint P,0.002).
doi:10.1371/journal.ppat.1000326.g003
Figure 4. Deficiency of B. burgdorferi lmp1 reduces the severity of carditis and arthritis in mice. (A) Representative histology of hearts
isolated from mice infected with wild type B. burgdorferi (WT), lmp1 mutant (lmp1
2), or lmp1 mutants complemented with lmp1 gene (lmp1 Com)
isolates analyzed two weeks following infection. The left panel indicates lower-resolution (46, bar=400 mm) and higher-resolution (206,
bar=80 mm) images of selected areas from corresponding sections (marked by box) shown in right panels. (B) Quantitative representation of the data
shown in Figure 4A. At least ten random sections from each spirochete group were scored for severity of carditis in blinded fashion on a scale of 0–3
as indicated in Materials and Methods. (C) Severity of joint swelling in B. burgdorferi–infected mice. Arthritis was evaluated by assessment of the
development of joint swelling of the mice infected with wild type B. burgdorferi (white bar), lmp1 mutant (gray bar), and lmp1 mutants
complemented with lmp1 gene (black bar) isolates, measured using a digital caliper on day 5, 10, 15, 21, and 28 following spirochetes challenge. Bars
represent the mean6SEM from three independent infection experiments. Differences in the joint swelling between groups of mice infected with
lmp1 mutant and those with the lmp1-complemented isolates were significant (P,0.003) at all time points, except for day 5. (D) Representative
demonstration of joint histology in mice infected with wild type or genetically manipulated B. burgdorferi isolates. Three weeks following spirochete
infection, tibiotarsal joints were analyzed for histopathology. Both lower-resolution (46, bar=400 mm, left panel) and corresponding higher-
resolution sections (206, bar=80 mm, marked by box, right panel) are shown. The arrows indicate the infiltration of inflammatory cells.
doi:10.1371/journal.ppat.1000326.g004
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primarily responsible for controlling spirochete burden in the host,
we explored whether reduced virulence of lmp1mutant spirochetes
correlates with the susceptibility of B. burgdorferi to the borreliacidal
activity of immune sera. To accomplish this, wild type, lmp1
mutant and lmp1-complemented B. burgdorferi were exposed to
antisera collected from B. burgdorferi–infected C3H mice. lmp1
mutants were significantly more susceptible to the bactericidal
Figure 5. Lmp1 contributes to B. burgdorferi defense against host-acquired immune responses. (A) lmp1 deletion does not influence B.
burgdorferi infectivity in severe combined immunodeficient (SCID) mice. Spirochete burdens in murine tissues (heart, joint, skin, and bladder) were
analyzed at days 7, 14, and 21 post-infection with wild type (white bar), lmp1 mutant (gray bar), and lmp1 mutant complemented with lmp1 (black
bar) B. burgdorferi and presented as copies of the B. burgdorferi flaB gene normalized against mouse b-actin. Bars represent the mean6SEM from two
independent infection experiments. Levels of B. burgdorferi isolates are similar in all murine tissues and timepoints (P.0.05). (B) Uptake of B.
burgdorferi by primary murine macrophages. Bone marrow-derived macrophages were isolated from C3H mice and incubated with wild type B.
burgdorferi (WT), lmp1 mutant (lmp1
2), and lmp1 complemented (lmp1 Com) isolates at an MOI of 10. Cells were fixed after 2 hr of spirochete
addition and processed for confocal immunofluorescence microscopy. Engulfed spirochetes (arrow), cellular actin, and nuclei were detected using
FITC-labeled anti-B. burgdorferi goat IgG, phalloidin-Texas Red, and DAPI, respectively. A representative image of three independent experiments with
similar results is presented (bar=20 mm). (C) The lmp1 mutant is highly susceptible to anti-B. burgdorferi antibody-mediated killing in vitro. The wild
type B. burgdorferi (WT), lmp1 mutant (lmp1
2), and lmp1 complemented (lmp1 Com) isolates were incubated in the presence of B. burgdorferi–
infected mouse serum. Serum used in the assay was pooled from B. burgdorferi–infected mice following 15 days of syringe-based infection (10
5 cells/
mouse). Upper panel represents spirochete viability after 24 and 48 hrs of additional B. burgdorferi–infected serum, as assessed by the increase in the
number of non-motile spirochetes using dark-field microscopy. Results are mean6SEM from three representative experiments with similar results.
Differences between lmp1 mutant and wild type B. burgdorferi or lmp1-complemented spirochetes were highly significant (*P,0.002). The lower
panel shows a representative fluorescence labeling of the live and dead spirochetes after 48 hr of antiserum treatment. Live bacteria were stained
green (Syto 9 stain) whereas the dead bacteria stained red (propidium iodide).
doi:10.1371/journal.ppat.1000326.g005
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and were protected by genetic complementation with lmp1
(Figure 5C). The susceptibility of lmp1 mutants to the bactericidal
activities of the immune sera did not differ significantly when using
active or heat-inactivated serum (data not shown), indicating that
lmp1 deletion enhances the borreliacidal effects of antibodies in a
complement independent manner. Like parental isolates, the lmp1
mutants were not susceptible to bactericidal activities by the non-
immune serum collected from naı ¨ve mice (data not shown),
suggesting that Lmp1 is not required for serum resistance by
spirochetes. Together, these data suggest that Lmp1 contributes to
B. burgdorferi defense against host-acquired immune responses by
enhancing resistance to the bactericidal antibodies that develop
during infection.
Discussion
In nature, B. burgdorferi is maintained through a complex
enzootic cycle [1]. Once transmitted to mammals, B. burgdorferi can
establish persistent infection in a variety of tissue locations. Limited
studies suggest that spirochete genes expressed in higher levels in
infected host tissues could be important for B. burgdorferi survival
[8]. Since membrane proteins could have a direct contribution to
the adaptation of pathogens to host environments, we assessed the
expression of 91 B. burgdorferi genes encoding potential membrane
proteins covering spirochete infectivity in multiple murine tissues.
Our data show that few of the genes analyzed are differentially or
highly expressed in the selected tissues. Targeted deletion of one of
the spirochete genes that is highly expressed in cardiac tissue, lmp1,
while resulting in the initial clearance of pathogen burden in
infected hearts, also affected overall virulence of B. burgdorferi in
murine infectivity and reduced the outcome of Lyme disease. Our
results show that lmp1 mutants persist in SCID mice at similar
levels to parental isolates and are susceptible to borreliacidal
antibody-mediated killing in vitro, suggesting that Lmp1 contributes
to B. burgdorferi defense against host-acquired immune responses.
Identification of hitherto unrecognized virulence genes of B.
burgdorferi, such as lmp1, that support pathogen infectivity in
mammals could shed light on the pathogenesis and prevention of
Lyme disease.
Genes that are selectively expressed in vivo could be important
for B. burgdorferi persistence in nature, possibly allowing spirochete
adaptation to highly heterogeneous metabolic and immune
environments. While assessment of pathogen gene expression in
vivo is an important prerequisite to understanding microbial
pathogenesis, microarray analysis is of limited use for the
assessment of the B. burgdorferi transcriptome in vivo, primarily
due to the low level of pathogen RNA in infected tissues [31].
Microarray studies were attempted after isolation and amplifica-
tion of microbial RNA [7,31], but this requires longer periods of
RNA manipulation and risks degradation or clonal alteration
during amplification and processing of transcripts. In contrast,
optimal quantities of B. burgdorferi RNA can be isolated from
spirochetes grown in vitro or in a host-implanted dialysis
membrane, and microarray-based studies have been used to assess
B. burgdorferi gene expression in these ‘host-like’ conditions that
have yielded important information on the role of B. burgdorferi
genes in pathogen infectivity [9,12,13,15,32]. However, the host
environment is too complex and dynamic to be duplicated
artificially. Therefore, we employed a sensitive qRT-PCR
approach for the direct assessment of pathogen gene expression
in vivo. This method is reproducible, as two independent sets of
animal infection studies identified the same set of 47 B. burgdorferi
genes as expressed in vivo, and a majority of them displayed higher
expression levels in mice, than in vitro. The variable expression of
these genes in multiple tissue locations possibly reflects the
adaptive responses of the pathogen to local host environments,
enabling immune evasion, adhesion, or nutrient uptake, among
other possibilities. Furthermore, regardless of their functional role
in pathogen persistence, antigens that are highly produced in
certain host sites, such as the joints and heart, could participate in
the genesis of inflammatory disease. Our qRT-PCR analysis also
identified a set of 44 B. burgdorferi genes that may not be important
for mammalian infectivity, as none of these displayed detectable
transcription within the first 4 weeks of infection. On the other
hand, a set of 26 genes encoding potential lipoproteins displayed
detectable expression in vivo and, with the exception of bbo40,
expression of many genes (bb0806, bbb09, bbd10, bbj09, bbl39,
bbm27, bbn38, bbn39, bbq47, bbs41) agreed with a previous study
that evaluated the expression of B. burgdorferi lipoproteins in murine
dermis [5]. Although our expression analysis identified selected B.
burgdorferi transcripts highly expressed in vivo, rather than proteins,
these mRNA are likely the signatures of translated antigens. This
speculation is supported by the recent study that identified 103
spirochete immunogens by screening in vitro translated genome-
wide proteomic arrays with B. burgdorferi-specific immune sera [33].
Our target list of potential membrane proteins (Table S1) overlaps
10 of these identified immunogens (BB0543, BBB09, BBH06,
BBL39, BBM27, BBN38, BBN39, BBO39, BBO40 and BBS41).
Each of these immunogens was represented in our identified set of
B. burgdorferi genes expressed in murine tissues (Figure S1).
Our study established B. burgdorferi lmp1 as a spirochete gene that
is highly expressed in the early stages of mammalian infection,
most notably in the murine heart. Lmp1 was first described in an
earlier study [34] which highlighted the protein as a potential B.
burgdorferi adhesin and indicated that Lmp1-specific antibodies
develop in B. burgdorferi–infected mammals. lmp1 does not belong
to the paralogous gene families in B. burgdorferi [24] and is thought
to encode a relatively large 128-kDa outer membrane protein with
putative type I signal peptide. It is not clear if the leader peptide is
indeed cleaved or if the hydrophobic N-terminus serves as a
membrane anchor; however, the antigen is exposed on the
spirochete surface. Lmp1 retains 86–88% amino acid identity
across orthologs in the related infectious spirochetes B. afzelii and
B. garinii, with the highest sequence conservation in the amino and
carboxyl termini. Analysis of the lmp1 locus indicates that the gene
overlaps with the immediate upstream gene, bb0209, and shares a
short intergenic region with the downstream gene, bb0211,
suggesting these three genes are likely part of an operon; however,
the lmp1 mutant is able to express both bb0209 and bb0211.
Notably, bb0211 encodes for the DNA mismatch repair protein,
MutL, and therefore likely bears a house-keeping function in B.
burgdorferi biology. Although the functions of bb0209 and lmp1 are
unknown, the amino terminus of BB0209 and the carboxyl
terminus of Lmp1 both contain multiple tetratricopeptide repeat
domains [35], which are shown to mediate protein-protein
interaction and the assembly of the pilus and multiprotein
complexes [36]. In addition, the central region of Lmp1 harbors
a unique cluster of seven repeat motifs, each consisting of 54
amino acids, which is highly conserved amongst Lmp1 orthologs
and potentially participates in adherence to host components [34].
Our studies further establish that Lmp1 is a surface-exposed
virulence factor of B. burgdorferi,a slmp1 deletion severely interferes
with spirochete infectivity and pathogenesis. After its inoculation
in the host, B. burgdorferi remains locally in the dermis for a few
days and then disseminates to distant organs, likely via the
bloodstream, during the first week of infection [37,38]. Our data
indicate that Lmp1 function may not be important during early
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differences in the burdens of wild type spirochetes and lmp1
mutants were observed in murine blood samples collected at day 3,
5 (data not shown) and 7 (Figure 2G). Instead, lmp1 mutants
displayed a severe reduction in numbers in the disseminated
organs by day 10, implying that Lmp1 is critical for the persistence
of the spirochete in murine tissues. In agreement with the higher
level of expression of lmp1 in the cardiac tissue, as compared to
other organs, a greater effect of lmp1 deletion was also observed in
the heart where the mutants were selectively eliminated after 10
days of infection, suggesting that Lmp1 plays a dominant role in
spirochete infection of the heart. B. burgdorferi burdens in mice
began to decline after first two weeks of infection [37], which
coincides with the development of the acquired immune response,
such as neutralizing antibodies that controls spirochete infection
[26,28]. This is consistent with the observation that lmp1 mutants
persist in similar levels to the parental isolate in the heart at day 7,
despite dramatic wild type expression of lmp1, but begin to decline
during the second week. The ability of lmp1 mutants to survive in
SCID mice further indicates that the function of the Lmp1 is not
related to metabolic requirements of the spirochete survival in vivo,
as shown for B. burgdorferi PncA [39] or AdeC [40], but rather is
associated with B. burgdorferi survival in host immune environ-
ments. B. burgdorferi isolates missing the lp28-1 plasmid [41], which
houses VlsE [42,43], display similar impaired host persistence in
immunocompetent mice, as VlsE likely confers protection against
host-generated borreliacidal antibodies. Therefore, while lmp1 is
variably expressed in diverse tissue environments and carries a
predominant role in spirochete persistence in the heart, a basal
level of lmp1 expression is noted throughout the murine infection
which, based on our in vitro data (Figure 5C), might contribute to
the protection of B. burgdorferi against host-acquired immune
responses, as was recently proposed for B. burgdorferi OspA in
feeding ticks [44].
In summary, we have identified a select set of B. burgdorferi genes
encoding potential membrane proteins that are expressed during
murine infection. Many of these in vivo-expressed genes are
differentially expressed in various host tissues, including joints and
heart, and can participate in pathogen persistence and the genesis
of disease. Here, we present direct evidence that one microbial
gene expressed at higher level in the cardiac tissue, lmp1, encodes
an essential virulence factor that plays an important role in
immune evasion and dramatically influences spirochete persis-
tence in murine tissues and the genesis of inflammation. Whereas
previously identified B. burgdorferi virulence antigens are mostly
plasmid-borne, and thus have greater instability and sequence
divergence, Lmp1 is chromosomally encoded and is relatively
conserved among orthologs in related infectious spirochetes.
Further identification of B. burgdorferi virulence determinants that
actively support spirochete persistence in vivo could contribute to
the development of effective therapeutic strategies against Lyme
borreliosis.
Materials and Methods
Bacteria, mice, and ticks
Borrelia burgdorferi infectious isolate A3 [45], a clonal derivative of
the B. burgdorferi whole genome sequenced strain B31 M1 [24,25],
was used in this study. Four- to six-week old female C3H/HeN
and pathogen-free NCr-SCID mice were purchased from the
National Institutes of Health. Mice were inoculated with a single
subcutaneous injection of 10
5 spirochetes per mouse. All animal
procedures were performed in compliance with the guidelines and
with the approval of the Institutional Animal Care and Use
Committee. Ixodes scapularis ticks used in this study belong to a
colony that has been reared and maintained in the laboratory.
Quantitative RT-PCR analysis
The identity and oligonucleotide primer sequences for the
quantitative RT-PCR analysis of B. burgdorferi genes are indicated
in Table S1. The B. burgdorferi target genes [24,25]were selected
based on their predicted localization on the spirochete membrane
according to the database annotation (www.tigr.org) and PSORT
in silico analysis [46]. Groups of mice (5 animals/group) were
infected with B. burgdorferi (10
5 spirochetes/mouse), and samples of
skin, heart, tibiotarsal joint and bladder were collected and frozen
in liquid nitrogen at one-week intervals between 1 and 4 weeks of
infection. Total RNA was extracted from tissue samples using the
TRIzol reagent (Invitrogen). To reduce traces of contaminating
DNA, samples were further digested with RNase-free DNaseI
(Qiagen), purified using the RNeasy kit (Qiagen) and reverse
transcribed to cDNA using the AffinityScript cDNA synthesis kit
(Stratagene). The relative levels of B. burgdorferi cDNA in each
sample were assessed by quantitative PCR (qPCR), and DNA
contamination in each sample was measured using an equal
volume of purified RNA as a template. Samples from each time
point were pooled by tissue type, and final pools of skin, heart,
joints and bladder were used in the qPCR analysis. The primers
used for qPCR reaction were designed using OligoPerfect Primer
design software (Invitrogen) based on the B. burgdorferi B31 M1
genomic sequence [24,25]. All PCR primer pairs had a similar
annealing temperature (60uC) and spanned 100–300 base pairs of
each of the target B. burgdorferi genes. Each primer pair was tested
for efficiency and non-specific amplification by melt-curve analysis
using B. burgdorferi genomic DNA as a template. In one case of
paralogous genes, the same set of primers was assigned for the
detection of both genes as indicated in Table S1. To generate
reliable in vivo gene expression data and to further ensure specific
amplification of B. burgdorferi cDNA in murine tissue samples, the
qPCR amplification in each well was followed by melt-curve
analysis, and wells showing non-specific amplification were
discarded from data analysis. The amplification cycle consisted
of initial denaturation at 95uC for 5 min followed by 45 cycles
each at 95uC for 10 sec, 60uC for 20 sec and 72uC for 30 sec and
final melt curve analysis: 55uC for 30 sec, increase 0.5uC per cycle
to 95uC. The amplification was performed in an iQ5 real-time
thermal cycler (Bio-Rad) using SYBR Green Supermix (Bio-Rad)
as detailed. For expression screening of B. burgdorferi genes, we
simultaneously assayed 8 candidate genes in each 96-well PCR
plate using duplicate wells of template cDNA (skin, heart, joint and
bladder samples) with parallel positive (B. burgdorferi genomic DNA)
and negative (no template) controls. Transcript levels of individual
genes were assessed in spirochetes grown in vitro in BSK medium
(10
7 cells/ml) and in each of the murine samples, calculated using
the 2
2DDCt method [47], normalized against flaB transcripts and
presented as fold increase in gene expression. Two independent
mouse experiments used the same parameters of gene expression
analysis to ensure the reproducibility of the assay. For detailed
temporal and spatial analysis of lmp1 expression by qRT-PCR
analysis, amounts of target transcripts were calculated from
standard curves prepared from known quantities of flaB and
lmp1 DNA as described [21,48]. Mice (5 animals/group) were
infected via single intradermal injection with B. burgdorferi (10
5
spirochetes/mouse) or via tick feeding using B. burgdorferi–infected
nymphs. Infected murine samples, the heart, skin, bladder and
tibiotarsal joints, were removed at different timepoints and frozen
in liquid nitrogen. B. burgdorferi–infected ticks were isolated by
allowing ticks to feed on 15-day infected mice as described [7]. For
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tissues, flaB transcripts were measured in infected samples and
normalized to mouse or tick b-actin levels.
Generation and phenotypic analysis of genetically
manipulated B. burgdorferi isolates
The oligonucleotide primers used for mutagenesis and genetic
complementation of B. burgdorferi are indicated in Table S2. The
lmp1-deficient B. burgdorferi was created by exchanging a 2068 base
pair DNA fragment encompassing the 59 terminus of the lmp1
gene with a kanamycin-resistance cassette via homologous
recombination as described [8]. Briefly, DNA fragments flanking
up- and downstream of the lmp1 gene were PCR-amplified using
primers P1–P4 and inserted into two multiple-cloning sites
flanking the kanAn cassette in plasmid pXLF10601 [49]. This
plasmid was sequenced to confirm the identity of the insert and
electroporated into wild type B. burgdorferi B31 isolate A3.
Transformants were selected for growth in the presence of
kanamycin (350 mg/ml). Ten clones were isolated and PCR
analysis was used to confirm the intended recombination event
using primers P1–P9. The presence of all endogenous plasmids
contained in the parental A3 isolate was also assessed in the
mutant clones as described [8]. One of the lmp1 mutant clones that
retained the same complete set of plasmids as the wild type isolate
was used in additional experiments.
Genetic complementation of the lmp1 mutant was achieved by
re-insertion of a wild type copy of the lmp1 gene in the B. burgdorferi
chromosome [20]. The upstream of the lmp1 open reading frame
(ORF) overlaps with the preceding gene by a few nucleotides,
lacking an intergenic region with a discernible promoter. We,
therefore, fused the lmp1 ORF with the B. burgdorferi flaB promoter
[50]. Two B. burgdorferi DNA fragments encompassing the full-
length lmp1 gene and the flaB promoter were PCR-amplified, fused
and cloned into the BamHI and SalI sites of pKFSS1 housing a
streptomycin-resistance cassette (aadA) [29]. A DNA element
containing the flaB promoter-lmp1 gene fusion and the aadA
cassette was cut with BamHI and SmaI from the recombinant
plasmid pKFSS1-lmp1 and inserted into the corresponding
restriction sites of the plasmid pXLF14301 [20] that contains the
required 59 and 39 arms for homologous recombination in the B.
burgdorferi chromosomal locus bb0444–0446. The plasmid construct
was sequenced to confirm its identity and 25 mg of the plasmid
DNA was electroporated into the lmp1 mutant. Four clones were
isolated by their ability to grow in the presence of both kanamycin
and streptomycin. PCR analysis was used to confirm the intended
recombination event, and one of the lmp1-complemented clones
that contained the same plasmid profiles as the wild type was
chosen for further study. For in vitro growth analysis, an equal
number of wild type and genetically-manipulated spirochetes were
diluted to a density of 10
5 cells/ml and grown at 33uC in BSK-H
medium until they reached the stationary phase (10
8 cells/ml).
Aliquots of spirochetes were assessed every 12 hours, under a
dark-field microscope, for motility, cell clumping and numbers of
spirochetes counted using a Petroff-Hausser cell counter.
For phenotypic analysis of lmp1 mutants and lmp1-complement-
ed isolates in vivo, B. burgdorferi were injected into groups of mice (10
animals/group) via needle-inoculation (10
5 spirochetes/mouse)
intradermally on the back. Mice were sacrificed at 7, 10, 15, 21
and 28 days following inoculation. Skin, heart, joints, bladder and
blood samples were collected and B. burgdorferi burdens were
measured by quantitative PCR analysis as previously described
[7,8]. Development of joint swelling in the infected mice was also
evaluated at similar time points as for spirochete burdens. For
histological evaluation, heart and joint samples were collected at
days 15, 21 and 28 following inoculation. For tick acquisition
studies, groups of mice (5 animals/group, 20 ticks/mouse) were
fed on by naı ¨ve ticks following two weeks of B. burgdorferi infection.
The ticks were allowed to feed to repletion and were immediately
analyzed for quantitative RT-PCR measurement of B. burgdorferi
burden as detailed earlier [7].
Antibodies, ELISA, and immunoblotting
Generation of murine polyclonal antibodies against recombi-
nant Lmp1, ELISA and immunoblotting were performed as
described [7,8]. Recombinant Lmp1 protein was produced in E.
coli using the bacterial expression vector pGEX-6P1 (Amersham-
Pharmacia Biotech) with specific primers as indicated in Table S2.
Expression, purification and enzymatic cleavage of the glutathione
transferase (GST) fusion proteins were carried out as detailed
[7,8]. Sixteen serum samples from humans with a clinical history
of Lyme disease, collected from the CDC Lyme patient serum
panel were used in the ELISA. Five serum samples from normal
individuals residing in non-endemic areas for Lyme disease were
also collected from CDC and used as negative controls. For
immunoblotting, recombinant Lmp1 (0.05 mg/lane) was resolved
on a SDS-PAGE gel and probed with 1: 1000 dilution of murine
or human serum. Murine antiserum was collected from a group of
5 mice, 15 days after infection with B. burgdorferi via syringe
inoculation (10
5 cells/mouse). Murine antiserum generated against
recombinant Lmp1 was used in a Proteinase K accessibility assay
to determine surface exposure of the Lmp1 as described [48].
Phagocytosis and in vitro killing assay
Bone marrow derived macrophages were isolated from naı ¨ve
C3H mice as described [51] and cultured for 5 days at 37uC
(2610
5 cells/well) in L929-conditioned DMEM media. The cells
were then washed and resuspended in serum-free DMEM and
incubated with B. burgdorferi at a multiplicity of infection (MOI) of
10 at 37uC for 2 hours. Cells were washed with cold PBS to
remove unbound B. burgdorferi and fixed in 3.7% paraformalde-
hyde, and processed for confocal immunofluorescence as de-
scribed [52]. Spirochetes, cellular actin and nuclei were detected
using FITC-labeled anti-B. burgdorferi goat IgG (KPL), phalloidin-
Texas Red (Invitrogen), and DAPI (Invitrogen), respectively.
Susceptibility of wild type or genetically manipulated spiro-
chetes to borreliacidal activities in infected mouse sera was
performed as described [53]. Briefly, spirochetes were grown in
BSK-H medium to a density of 10
7 spirochetes/ml and exposed to
active or heat-inactivated 50% sera isolated from mice infected for
15 days with B. burgdorferi. Samples were incubated at 33uC for 24
to 48 hours and spirochete viability was assessed using dark-field
microscopy. Susceptibility of spirochetes to borreliacidal activities
in infected mouse sera were also tested in parallel using a
combination of two vital stains that specifically label live and dead
spirochetes, as described [8]. Briefly, spirochetes were incubated
for 48 hours and labeled with the live/dead BacLight Viability kit
(Invitrogen) according to the manufacturer’s instructions.
Evaluation of arthritis and carditis
B. burgdorferi–infected mice were examined for swelling of the
tibiotarsal joints as detailed earlier [8]. Ankle joints from each of
the rear legs of each mouse were measured using a precision
metric caliper in a blinded fashion. The thickest diameters of the
tibiotarsal joints were measured in each mouse prior to B.
burgdorferi infection, and the development of ankle swellings was
monitored and tabulated on a weekly basis until the sacrifice of the
mice. For histological evaluations of arthritis and carditis, at least 5
ankle joints and 5 hearts were collected from each group of mice (5
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joints and hearts (cut in half through bisections across the atria and
ventricles) were fixed in 10% formalin and processed for
Hematoxylin and Eosin staining. Twenty randomly chosen
sections from each mouse group were assessed for histopatholog-
ical comparisons. Signs of arthritis were evaluated as described [8],
based on a combined assessment of histological parameters of B.
burgdorferi-induced inflammation [54–56], such as exudation of
fibrin and inflammatory cells into the joints, alteration in the
thickness of tendons or ligament sheaths, and hypertrophy and
hyperplexia of the synovium. Signs of carditis [54,57] were
evaluated based on the cardiac inflammatory infiltrate, including
the transmural infiltration of neutrophils in the blood vessels and
infiltration of surrounding connective tissue with macrophages.
Carditis was scored on a scale of 0 (no inflammation), 1 (mild
inflammation with less than two small foci of infiltration), 2
(moderate inflammation with 2 or more foci of infiltration), or 3
(severe inflammation with focal and diffuse infiltration covering a
large area). Both joint and heart tissue sections were blindly
examined by two independent researchers.
Statistical analysis
Results are expressed as the mean6standard deviation (SD) or
standard error mean (SEM). The significance of the difference
between the mean values of the groups was evaluated by two-tailed
Student t test.
Supporting Information
Figure S1 Relative expression of selected B. burgdorferi genes
duringinfectionofthemurinehosts.TotalRNAwasisolatedfromB.
burgdorferi growninvitro,and multipletissues ofmice, between1 and 4
weeks of B. burgdorferi infection, were pooled by tissue type and
converted to cDNA for measuring gene-specific transcripts using
quantitativePCR.Fold increaseintheexpression of individual genes
in each of the murine samples was calculated based on threshold
cycle (Ct) values using the 2
2DDCt method [47], normalized against
flaB Ct values. Bars represent the mean6SD from four quantitative
PCR analyses of two independent infection experiments.
Found at: doi:10.1371/journal.path.1000326.s001 (0.8 MB EPS)
Figure S2 lmp1 is highly expressed in the murine heart during
early phases of tick-borne B. burgdorferi infection. Total RNA was
isolated from multiple murine tissues following 7 days of challenge
with B. burgdorferi–infected nymphal ticks (5 ticks/mouse, 3
animals/group), converted to cDNA, and used for measuring
lmp1 transcripts in quantitative PCR assay. The relative expression
levels of lmp1 are presented as copies of lmp1 transcript per 1,000
copies of flaB transcripts. Bars represent the mean6SEM from
three independent experiments. The transcript levels of lmp1 in the
heart were significantly higher than corresponding expression
levels in the skin, joint, or bladder (*P,0.02).
Found at: doi:10.1371/journal.path.1000326.s002 (0.4 MB EPS)
Figure S3 Recognition of B. burgdorferi Lmp1 by immune sera.
(A) Development of Lmp1-specific antibody response in B.
burgdorferi–infected mice and humans. Fifty nanograms of recom-
binant Lmp1 was probed with normal and B. burgdorferi–infected
sera. Arrow indicates the development of Lmp1-specific antibody
response in both B. burgdorferi–infected mice and human sera.
Infected serum used for immunoblotting was pooled from infected
mice following 15 days of syringe-based infection or from a Lyme
disease patient as detailed in the text. (B) Reactivity of antibodies
in human sera to recombinant Lmp1 as assessed by ELISA. Sera
from randomly chosen normal healthy controls (n=5) and Lyme
disease patients (n=16) were tested for detection of antibodies
specific for recombinant Lmp1.
Found at: doi:10.1371/journal.path.1000326.s003 (0.3 MB EPS)
Figure S4 Detection of native B. burgdorferi Lmp1. Murine
antibodies generated against Lmp1 specifically recognize native
protein in B. burgdorferi. One microgram of B. burgdorferi lysates was
probed with normal mouse serum (NMS) or murine anti-serum
against Lmp1 (anti-Lmp1). Murine polyclonal antibodies used in
the immunoblotting were generated by immunization of mice
against recombinant Lmp1 in mice as described in the text. Arrow
indicates detection of native B. burgdorferi Lmp1.
Found at: doi:10.1371/journal.path.1000326.s004 (0.3 MB EPS)
Table S1 Oligonucleotide primers used in the study
Found at: doi:10.1371/journal.path.1000326.s005 (0.2 MB DOC)
Table S2 Oligonucleotide primers used in the study
Found at: doi:10.1371/journal.path.1000326.s006 (0.07 MB
DOC)
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